Listed on the Singapore Stock Exchange, Biolidics Limited (“Biolidics” or “the Company” and together with its subsidiaries “the Group”) focuses on developing a portfolio of innovative diagnostic solutions to lower healthcare costs and improve clinical outcomes.

To diversify our business model and build long term growth, the Group is also actively exploring technology-enabled lifestyle businesses, which would involve the ownership, operation and management of Multi-Channel Networks ("MCN") businesses, live streaming social e-commerce platforms and Esports-related businesses.